Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance. Emerging research reveals that the ...
A groundbreaking study from Tata Memorial Hospital shows that using ultra-low doses of nivolumab, an immunotherapy drug, can effectively treat cancer while drastically reducing costs by 90%. This ...
Doctors debunk viral myths about cancer diets, clarifying that sugar does not directly cause cancer and fasting cannot prevent it. Experts stress balanced nutrition and evidence-based treatment for ...
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results